AltaThera Pharmaceuticals at ACC.24

AltaThera at ACC.24

Chicago, IL – March 20, 2024 – AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming American College of Cardiology 2024 annual meeting in Atlanta, Georgia from April 6-8. With attendees coming from around the world, ACC.24 provides an ideal venue to learn about the latest science and practice-changing updates in cardiovascular care.

Sotalol IV’s rapid 1-hour loading dose allows healthcare practitioners to quickly assess a patient’s response to sotalol at chosen therapeutic levels and potentially reduce patient length of stay and increase bed availability at their institutions.

ACC.24 attendees will be able gain insight into one health system’s experience with Sotalol IV by attending the April 6 poster presentation, “Real-World Comparative Effectiveness and Safety of Intravenous to Oral Sotalol Loading Among Patients with Atrial Arrhythmias”, authored by Keturah Weaver, PharmD, BCPS, Benjamin Heikkinen, PharmD, BCIDP, and Melinda Novak, PharmD. For more information about this poster and the conference program, please visit the ACC.24 website at

To hear more about the latest clinical data on Sotalol IV, come by booth #1809 at ACC.24 in Atlanta or visit our website at


About Sotalol IV
Sotalol IV is an antiarrhythmic indicated for:

  • The maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation / atrial flutter in patients with symptomatic AFIB/AFL] who are currently in sinus rhythm.
  • The treatment of life-threatening ventricular tachycardia.

About AltaThera
AltaThera is a precision medicine company using innovative science to improve patient care and solve serious and costly problems. AltaThera’s aim is to narrow the gap between scientific innovation and clinical decision-making by individualizing drug treatment so that the right patient can receive the right dose at the right time. AltaThera is based in Chicago, Illinois, USA. For more information, visit

Sotalol IV [package insert]. Chicago, IL: AltaThera Pharmaceuticals; 09/2023. 

Please see Sotalol IV Highlights of Prescribing Information and full Prescribing Information at, including boxed warning, contraindications, and dosing.